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pediatric population from Colombia
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Abstract
Background: There are different genetic patterns for cardio-metabolic parameters among different populations.
Additionally, it has been found that ancestral genetic components (the proportion of Amerindian, European and
African) in admixed Latin American populations influence an individual’s susceptibility to cardio-metabolic disorders.
The aim of this study was to evaluate the effect of ancestral genetic composition on a series of cardio-metabolic
risk factors in a young admixed population from Colombia.
Results: In a sample of 853 Colombian youth, 10 to 18 years old, the mean European contribution was 66.6 %
(range: 41–82 %), the mean African contribution was 14 % (range: 4–48 %), and the mean Amerindian contribution
was 19.4 % (range: 10–35 %) using a panel of 40 autosomal ancestry-informative markers (AIMs). We assessed the
degree of association between ancestral African, Amerindian and European genetic components and measures of
body mass index, waist circumference, fasting glucose, fasting insulin, insulin resistance, triglycerides, high-density
lipoprotein, and systolic and diastolic blood pressure. Two of the nine measures assessed presented a nominal
significant association with ancestral components after adjusting for confounding variables: triglyceride levels were
associated with the Amerindian component (OR = 1.06, 98.3 % CI = 1.01–1.11, P = 0.002) and systolic blood pressure
was associated with the European component (OR = 0.93, 98.3 % CI = 0.87 to 0.99, P = 0.008) and the African
component (OR = 1.07, CI = 1.01–1.14 P = 0.008), although it was not significant following a global Bonferroni
correction. Additionally, insulin levels and insulin resistance showed associations with the African component.
Conclusions: Our findings support the idea that an Amerindian ancestral component may act as a risk factor for
high triglyceride levels. In addition, an African ancestral component confers a risk for high systolic blood pressure,
and a European ancestry serves as a protective factor for this condition in a young admixed population from
Colombia. However, these results should be confirmed in a larger population.
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Background
The genomic composition of Latin American (LA) pop-
ulations is the result of a tri-ethnic genetic admixture
that occurred during the colonization of the American
continent. This process has been documented with his-
torical data and initially corroborated via lineage-based
tests, which target mitochondrial DNA and the non-
recombining Y chromosome [1, 2]. Subsequently, with
the discovery of an autosomal marker-based test to de-
tect sequences with large differences in their allelic fre-
quencies among continental populations (δ), called
ancestry-informative markers (AIMs), it has been pos-
sible to infer the proportions of each of the three ances-
tral components in an admixed LA genome [3, 4]. Using
AIMs, the ancestral genetic compositions of several LA
populations, including the Colombian population, have
been determined [3, 5]. The results show that the major-
ity of LA populations were founded by a complex ad-
mixture process among three continental populations
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(Amerindian, African and European), although the pro-
portions vary among – and even within – countries [6].
Knowledge of the ancestry of Latin American popula-
tions has different applications, ranging from forensic
and anthropological uses to informing biomedical sci-
ences, and can be especially useful in the identification
of gene variants associated with both infectious and
complex diseases [7, 8].
Using genetic admixture as a tool to identify gene vari-
ants involved in complex diseases requires differences in
allelic frequencies among the parental population and
recent occurrence of admixture mating among those
parental populations. The genetic admixture is a factor
that influences the allelic frequencies in a population
and this, in part, contribute to explaining the differences
observed in the epidemiology of certain diseases in
admixed population regarding parental populations.
These two conditions are fulfilled in the Colombian
population because the diseases involved in cardio-
metabolic disorders, such as obesity, type 2 diabetes
mellitus (T2D), hypertension and dyslipidemia, have dif-
ferent prevalences in European, African and Amerindian
populations [9] and because the demographic history of
the genetic admixture is very recent [5]. Globally, the
prevalence of overweight and obesity varies across differ-
ent regions. In adults, it is the highest in the Americas
(61.3 %) and is the lowest in Africa (30.8 %). The preva-
lence of diabetes is the highest in the American/Caribbean
region and the lowest in Africa (12.9 % and 3.2 %, respect-
ively), whereas the prevalence of high blood pressure in
adults is the highest in Africa (30 %) and is lower in the
Americas (18 %). Finally, the prevalence of elevated total
cholesterol is the highest in Europe (54 %) and the lowest
in Africa (22.6 %) [9, 10] (See Additional file 1: Table S1).
Because of this heterogeneity, genetic admixture stud-
ies provide a unique opportunity to account for the
heterogeneity of population-based differences and to
understand the role of genetic factors that contribute
to disease risks in admixed populations. However,
there have been no studies evaluating the effect of
ancestry on cardio-metabolic parameters conducted
on people under 18 in the Colombian population. Fi-
nally, the identification of the effect of genetic vari-
ants in the prevalence of such diseases requires that
the effect of variables that interfere with this associ-
ation, such as socio-economic status, parental educa-
tion, physical activity and diet, be assessed using a
control. Based on the above information, we aimed to
evaluate the association between individual and aver-
age estimates of genetic ancestry and the anthropo-
metric, biochemical and clinical measurements used
to assess cardiovascular risk factors in a Colombian
population of admixed youth while adjusting for en-
vironmental factors.
Methods
Population of the study
A cross-sectional study of 853 unrelated, self-identified
healthy volunteers of both sexes between 10 and 18 years
old was performed. The population base for subject re-
cruitment was the population examined in following
study: “Metabolic Syndrome in overweight youth: Identi-
fication of risk factors and evaluation of an interven-
tion.” The participants were affiliated with a company
that provides health services in the city of Medellin in
northwest Colombia. The exclusion criteria were defined
as follows: young people who used corticosteroids or
thyroid hormones; those who were hypoglycemic; those
diagnosed with diabetes, chronic renal failure, or innate
metabolism-related genetic diseases; those with physical
or mental disabilities; those who were highly competitive
athletes; and those who were pregnant or nursing. This
study complied with the Declaration of Helsinki ethical
principles for medical research involving human sub-
jects. The researchers complied in all cases with Reso-
lution 8430 of 1993, from the Colombian Ministry of
Social Protection.
General socioeconomic and health information
The participants and their guardians answered a ques-
tionnaire and provided general information, including
sex, date of birth and socioeconomic status, according
to the National Administrative Department of Statistics
(Departamento Administrativo Nacional de Estadística,
DANE), which has established six socioeconomic cat-
egories based on housing location, with stratum 1 being
the lowest and 6 the highest [11]. For the purpose of this
analysis, the data obtained for the socioeconomic strata
were classified into three categories: low (1 and 2), mid-
dle (3 and 4) and high (5 and 6). Pubertal maturation
was based on a self-evaluation performed by the subjects
according to the Tanner Sexual Development Stages
using pictures or schematic drawings [12, 13]. In
addition, information on birth weight and the duration
of breastfeeding was obtained.
Phenotypes
For this study, cardio-metabolic risk factors were defined
as follows: waist circumference (WC) ≥ the 90th per-
centile for the individual’s age and sex (according to
values reported in the III National Health and Nutrition
Examination Survey (NHANES) for Mexican-American
youth) [14]; triglycerides (TGs) ≥110 mg/dL; HDL chol-
esterol ≤40 mg/dL; systolic or diastolic blood pressure
≥the 90th percentile for the individual’s age, sex and
height; and fasting blood glucose ≥100 mg/dL. Addition-
ally, overweight (body mass index (BMI) >85th percent-
ile; insulin >23.0 μU/mL and insulin resistance (IR)
(HOMA >3.1) were determined. IR was estimated using
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the Homeostasis Model Assessment (HOMA-IR) using
the HOMA Calculator Version 2.2.2 software from the
©Diabetes Trials Unit from Oxford University. Each of
the measures were obtained using standardized proto-
cols and calibrated equipment as referenced by previous
studies [15].
Environmental covariates
Food intake was assessed using a 24-hour reminder,
which was randomly distributed on different days of the
week. A second reminder was given in a random sub-
sample and on non-consecutive days to estimate and ad-
just for individual variability. The level of physical activity
was determined using the University of South Carolina
Arnold School of Public Health’s 3-Day Physical Activity
Recall (3DPAR) questionnaire, in which participants were
asked questions about their physical activity (PA) for
the three previous days (two weekdays and one week-
end day). For the purposes of this analysis, the data
obtained were classified into three final levels: low,
moderate, and high [16].
Genetic ancestry estimation
To infer the individual and average ancestries of the par-
ticipants, 40 AIMs widely distributed across the genome
that show differences in the allele frequencies (higher
than 40 % between at least two populations) among the
European, Amerindian and African parental populations
were selected. AIMs were selected using the previously
available population data included in the Marshfield
Clinic diallelic insertion/deletion polymorphism database
[17], a database of retrotransposon insertion polymor-
phisms in humans (dbRIP) [18], and from studies that
have also characterized markers for Latin American pop-
ulations [4, 19]. Detailed information about the 40 AIMs
are shown in Additional file 1: Table S2 and Table S3.
DNA was extracted from peripheral blood using a stand-
ard method [20]. The concentration and quality of the
samples were determined via spectrophotometry. The
AIMs were typified using PCR-RFLP (polymerase chain
reaction – restriction fragment length polymorphism)
analysis and based on the differences in the amplified
fragment sizes (in cases of an In/Del) using capillary
electrophoresis in an ABI-PRISM 310 genetic analyzer
(Applied Biosystems). Genotype determination was per-
formed using the GeneMapper v 4.0 program.
Statistical analysis
The assumption of normality of the quantitative vari-
ables was evaluated using the Kolmogorov-Smirnov
test. The qualitative variables were presented with
their frequency distributions; the quantitative variables
were summarized according to their median and
interquartile ranges. Food consumption data were
analyzed based on the Program Evaluation of Dietary In-
take (Evaluación de la Ingesta Dietética, EVINDI v4) [21].
Reports of nutrient intake were processed using the pro-
gram PC SIDE (Personal Computer Version of Software
for Intake Distribution Estimation) v 1.0. The allele and
genotypic frequencies were calculated with the PLINK v.
1.07 program [22]. Ancestry proportions were calculated
with the ADMIXMAP v 3.2 program [23], which uses a
frequentist-Bayesian method. The analysis of median dif-
ferences was performed using Mann-Whitney U or
Kruskal-Wallis tests. Individual cardio-metabolic parame-
ters (body mass index, waist circumference, HDL choles-
terol, systolic or diastolic blood pressure, fasting blood
glucose, and insulin resistance) were coded as binary vari-
ables based on the cutoff values described above. Logistic
regression analysis was performed using the dichotomous
variables as an independent model to assess the effect of
each of the genetic ancestries on each cardio-metabolic
parameter. Because of the known effects of socioeco-
nomic status, parental education, physical activity and
diet on these components, each of these covariates
were included in the model as control variables. Ana-
lyses were conducted with SPSS (Statistical Package
for the Social Sciences) v. 19.0 statistical software and
PLINK v. 1.07 [22]. Because all associations assessed
were based on a priori hypotheses, both unadjusted
and adjusted probability values are reported. The sig-
nificance test were adjusted by the Bonferroni
method, two threshold significance as a p-value
<0.05/3 = 0.0167 (three ancestry), and p-value <0.05/
27 = 0.0018 (global correction, three ancestries * nine
cardio-metabolic parameters) was considered signifi-
cant for avoiding the error of multiple testing. The
threshold of significance for all other comparisons
was p <0.05.
Results
General characteristics of the study population
A total of 853 young volunteers (10 to 18 years old)
from a region of Colombia (Medellín) were included in
the study. The average age was 14 ± 2.4 for both male
and female. Of the volunteers, 52 % were female, 42 %
belonged to the middle socioeconomic stratum, and
54 % were classified as post-pubertal. As for the peri-
natal and environmental variables, 86 % had an adequate
birth weight and 9 % breastfed for less than a month;
29 % of the youth watch TV for >4 h per day; and 33 %
engaged in low levels of physical activity. The median
energy intake was 2253 kcal/day. Diets consisted of 13 %
protein, 55 % carbohydrates and 32 % fat. Table 1 shows
the demographic, perinatal, physical activity and food
consumption values in relation to each of the cardio-
metabolic parameters.
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Females 69.1 (63.4–74.8)** 22.0 (19.7–24.8) 82 (77–88)** 10,2 (7.5–14.7)** 1.3 (1.0–1.9)** 94 (70–135) 51 (43–60) 62 (60–70)** 101 (100–110)**
Males 73.3 (67.2–79.9) 21.9 (19.6–25.0) 85 (80–91) 8.3 (5.8–12.8) 1.0 (0.7–1.6) 91 (63–133) 50 (41,5–58) 70 (61–74) 110 (101–118)
Age groupa
10 to 13.9 68.9 (63.0–75.3)** 21.2 (18.6–23.8)** 83 (78–88)** 9.1 (6.4–13.2)* 1.2 (0.8–1.7) 92 (68–131) 52 (44–60)** 62 (60–70) 102 (100–110)**
14 to 18 73.0 (68.1–79.9) 23.0 (20.6–25.9) 85 (80–90) 9.8 (6.9–14.7) 1.2 (0.9–1.9) 93 (65–138) 48 (41–58) 68 (62–73) 110 (101–119)
Socioeconomic Statusb
Low 70.0 (63.7–77.2) 21.9 (19.2–25.0) 84 (79–90)* 9.3 (6.4–14.0) 1.2 (0.8–1.8) 98 (70–143)** 50 (42–57)* 64 (60–70)** 105 (100–112)
Medium 70.6 (65.2–76.9) 22.0 (20.0–24.9) 84 (79–90) 9,4 (6,8–13,7) 1.2 (0.9–1.8) 97 (68–136) 50 (42–60) 64 (60–70) 106 (100–115)
High 71.0 (66.0–78.0) 21.9 (19.7–25.1) 81 (77–88) 9,4 (6,4–13,2) 1.2 (0.8–1.7) 78 (59–106) 53 (45–62) 70 (61–70) 105 (100–115)
Pubertal maturationb
Prepubertal 67.3 (62.5–75.8)** 20.5 (18.1–23.5)** 84 (78–89) 8.3 (5.2–13.8)** 1.1 (0.7–1.7) 97 (66–147) 53 (42–60)* 62 (60–70)** 100 (100–109)**
Pubertal 69.5 (63.0–76.1) 21.5 (18.7–24.0) 82 (78–88) 9.2 (7.1–12.8) 1.1 (0.9–1.7) 89 (67–127) 52 (45–60) 64 (60–70) 105 (100–112)
Postpubertal 72.3 (67.4–78.4) 22.9 (20.5–25.5) 84 (79–90 9.9 (6.7–14.1) 1.2 (0.9–1.8) 92 (67–134) 48 (42–58) 66 (60–70) 109 (100–116)
Birth weight, (g)b
Low (<2500) 68,8 (64.5–77.2) 21.2 (19.4–23.8) 82 (75–89) 9.6 (7.5–15.1) 1.2 (0.9–2.0) 92 (70–133) 48 (40–55) 67 (60–70) 106 (100–110)
Adequate (≥2500–4000) 70.2 (64.5–77.0) 21.9 (19.6–24.8) 84 (78–89) 9.2 (6.4–13.5) 1.2 (0.8–1.7) 92 (67–132) 50 (43–59) 64 (60–70) 105 (100–114)
High (>4000) 73.1 (68.1–79.0) 22.5 (20.6–25.9) 82 (78–87) 8.5 (5.8–13.6) 1.1 (0.7–1.8) 83 (63–123) 51 (42–61) 64 (60–70) 109 (100–115)
Duration of breastfeeding, (months)b
>6 70.0 (63.8–76.9)** 21.7 (19.2–24.8)** 84 (79–90) 9.1 (6.3–13.6)* 1.2 (0.8–1.7)** 92 (67–127) 50 (43–60) 64 (60–70) 105 (100–114)
>3–6 69.6 (64.1–76.0) 21.7 (19.6–24.6) 82 (78–87) 9.2 (7.2–13.2) 1.2 (0.9–1.7) 97 (73–136) 51 (44–61) 64 (60–70) 105 (100–112)
>1–3 70.5 (65.5–77.8) 22.0 (20.1–25.1) 85 (77–91) 9.6 (6.4–13.4) 1.2 (0.8–1.7) 85 (63–151) 51 (42–58) 67 (61–71) 106 (100–115)
0–1 75.1 (69.9–82.0) 23.2 (20.9–26.7) 84 (79–90) 11.3 (7.5–17.3) 1.5 (0.9–2.2) 90 (63–138) 48 (42–58) 66 (60–74) 110 (100–119)
Time of television and video games, (hours)b
<2 69.5 (63.2–75.8)** 21.3 (18.9–24.0)** 83 (77–88) 8.8 (6.1–12.7) 1.1 (0.8–1.6) 85 (65–132)* 51 (44–60) 65 (60–70) 105 (100–115)
2–4 70.1 (64.6–77.0) 21.8 (19.7–24.9) 84 (79–90) 9.4 (6.9–13.5) 1.2 (0.9–1.7) 93 (67–128) 51 (44–60) 65 (60–70) 106 (100–114)













Table 1 Characteristics of the study population, stratified according to cardio-metabolic parameters (Continued)
Physical activityb
High 70.9 (64.5–77.7) 21.6 (19.3–24.6)* 83 (78–89) 7.9 (5.5–11.8)** 1.0 (0.7–1.5)** 84 (60–126)** 52 (44–60)** 68 (60–71)* 108 (100–113)
Moderate 70.2 (64.3–76.6) 22.0 (19.7–24.9) 84 (78–89) 9.9 (7.1–13.8) 1.2 (0.9–1.7) 98 (73–141) 51 (43–59) 64 (60–70) 104 (100–115)
Low 70.9 (65.6–77.4) 22.4 (20.0–25.3) 84 (79–90) 10.6 (7.7–15.5) 1.4 (1.0–1.9) 97 (71–137) 48 (42–57) 64 (60–70) 105 (100–114)
Percent of calories from simple carbohydrate
≤10 70.4 (64.6–76.4) 21.7 (19.9–24.6) 83 (78–89) 8.8 (6.3–12.8)* 1.1 (0.8–1.6)* 84 (60–125)** 53 (44–61)** 64 (60–70) 105 (100–114)
>10 70.5 (64.8–77.5) 22.0 (19.5–25.0) 84 (78–90) 9.8 (6.9–14.1) 1.2 (0.9–1.8) 96 (69–141) 49 (42–58) 64 (60–70) 105 (100–114)
Consumption of fruits daily
Yes 69.2 (63.1–75.6)** 21.5 (19.1–23.9)** 82 (77–88)** 8.8 (6.0–12.2)** 1.1 (0.8–1.55)** 89 (65–128) 51 (43–60) 64 (60–70) 103 (100–112)*
No 71.0 (65.6–77.9) 22.3 (20.0–25.3) 84 (79–90) 9.8 (6.9–14.7) 1.2 (0.9–1.8) 94 (68–137) 50 (42–59) 64 (60–70) 106 (100–115)
Data presented in median and interquartile range. BMI body mass index, WC waist circumference, TG triglycerides, HDL high density lipoprotein, DBP diastolic blood pressure, SBP systolic pressure arterial. Significant













Estimation of ancestry and its effects in relation to each
of the cardio-metabolic parameters
The range of European ancestry was 41–82 %; African,
4–48 %; and Amerindian, 10–35 %. The average ances-
tral percentages of the 853 young people were 66.6 ±
5.7 % European, 14.0 ± 4.7 % African, and 19.4 ± 4.1 %
Amerindian. The individual admixtures are shown in
Additional file 1: Table S4 and Figure S1. Dirichlet distri-
butions of the proportions of European, African, and
Amerindian ancestral components in the study popula-
tion are shown in Fig. 1. Median differences and logistic
regression model analyses were performed after recoding
each of the cardio-metabolic parameters to convert them
into binary variables. Our bivariate analyses revealed that
the subjects with high TGs had a higher percentage of
the Amerindian ancestry (P = 0.001) and less European
ancestry (P = 0.007) than those with normal values. The
subjects who had a high SBP had a lower European an-
cestry component (P = 0.002) and a higher African com-
ponent (P = 0.013) in comparison with those who had
normal SBP values. Subjects who had high insulin levels
and HOMA-IR measurements had a higher percentage
of African ancestry (P = 0.029 and P = 0.036, respectively)
than those who had normal values in these parameters
(Table 2). The values for BMI, WC, glucose levels, HDL
and DBP did not show significant differences in relation
to any of the ancestries.
The logistic regression model included ancestry as the
principal independent variable and was adjusted for age,
sex, pubertal maturation, socioeconomic stratum, phys-
ical activity, percent of calories from simple carbohy-
drates, daily consumption of fruits and BMI. Even
though some of the covariates were not significantly as-
sociated with the outcome variables in Table 1, some of
them were included, as they have been previously re-
ported to be important factors. Amerindian ancestry was
associated with an increased risk for elevated TGs for
each percentage unit increase in Amerindian ancestry;
specifically, the probability of having high TGs increases
by 6 % (OR = 1.06, 98.3 % IC = 1.01–1.11, P = 0.002).
After the adjustments described above, no effect of the
European ancestry was found on TGs levels, but a
protective effect was found for high SBP; for each per-
centage unit increase in European ancestry, the probabil-
ity of having high SBP decreased by 7 % (OR = 0.93,
98.3 % IC = 0.87–0.99, P = 0.008). However, an African
ancestry was positively associated with a risk for high
SBP; for each percentage unit increase in African ances-
try, the probability of having high SBP increased by 6 %
(OR = 1.07, 98.3 % IC = 1.01–1.14, P = 0.008) (Table 3).
Discussion
This study evaluated the association of ancestry with the
following cardio-metabolic risk factors in a young popu-
lation that was the product of ancestral mixture: WC,
BMI, glucose, insulin, HOMA-IR, TGs, HDL, DBP and
SBP. This analysis was based on 40 AIMs whose deltas
(δs) among the Amerindian, European and African pop-
ulations indicate that they are good discriminators (Add-
itional file 1: Table S1). The average and individual
results obtained for the ancestries of the sample popula-
tion match the data obtained by other researchers in the
same population using different types and numbers of
AIMs [6, 8, 24]. We must note, in interpreting the fol-
lowing results, that we set two threshold significance as
p <0.0167 (three ancestry), and p <0.0018 (three ances-
tries * nine cardio-metabolic parameters) to provide a
conservative Bonferroni correction for multiple testing,
however it may be unnecessarily rigorous when there is
a priori evidence of the associations being tested. This
study, using a multivariate analysis, showed an associ-
ation positive between African ancestral components
and SBP (Table 3), which has been widely reported in
genetic studies of blood pressure (BP) conducted in Afri-
can populations and in populations that are the product
of genetic admixture with African populations, such as
Latin American populations, including one study on an
adult population from the same region where the
present study was conducted [25–27]. However, despite
the consistently demonstrated effect of an African ances-
try component on blood pressure, other studies in the
United States have found no differences in the blood
pressure of children with different ethnic origins [28]. In
this study, the inverse relationship found between SBP
Fig. 1 Dirichlet distribution of the ancestral components of the study population. The figure shows the Dirichlet distribution of the ancestral
components of the study population using 40 ancestral informative markers (AIMs)
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and a European ancestral component in young people
from 10 to 18 years of age agrees with the findings in
adults.
TG levels were positively associated with an Amerin-
dian ancestral component, which agrees with some stud-
ies conducted on adult populations where it has been
reported that Amerindian women have higher TGs
levels than African American (AA) or European-
American (EA) women. Additionally, the prevalence of
dyslipidemia (low HDL, high LDL or high TGs) is
greater in Amerindian than in European populations
[29]. In 2014, Ko et al. identified eight gene variants as-
sociated with dyslipidemias. In inferring the ancestral
state, they found that seven of these variants were of an
Amerindian ancestry [30].
With regard to the HOMA-IR and insulin measure-
ments, a significant difference was found when a com-
parison of medians was carried out with the African
ancestral component. Although there was no significant
difference shown by the logistic regression, it is useful to
discuss these results because several studies have associ-
ated insulin resistance with African ancestry [31, 32]. In-
sulin and HOMA-IR are measurements related to T2D,
and other studies have found a high prevalence of this
disease in some AA populations [33, 34]. In addition, in
a study carried out on adults from the same region from
which the subjects of this study come, a significant asso-
ciation was found between the African ancestral compo-
nent and the risk of T2D. This association reinforces the
importance of considering the hypothesis of the “thrifty
genotype” that has been described for North American
populations, such as the Pima Indians [34], in whom
there is a very high prevalence of T2D. This prevalence
is believed to be related to the presence of genes variants
adapted to the dispersion of these populations across the
Bering Strait [34]. Other studies in admixed populations
found no association of the Amerindian component with
fasting blood glucose levels or with HOMA-IR [25, 35].
In two studies, one conducted in Medellín [17] and the
other in Mexico [18], where a positive association of
T2D with the Amerindian genetic component was re-
ported, the authors suggest that this association could be
explained because the low socioeconomic stratum has a
higher Amerindian genetic component than that of the
other strata, and the lifestyle and environmental factors
of this stratum favor the development of T2D. The eti-
ology of this complex trait has a high epigenetic compo-
nent; it has been demonstrated that early exposure to
hyperglycemia predisposes individuals to changes in
their chromatin and gene expression, which can be trans-
mitted from one generation to another (metabolic mem-
ory), and this might be what was observed in the African
Table 2 Comparison of medians of European, African and Amerindian ancestry according to components of metabolic syndrome
European African Amerindian
n (%) Median (IQR) Median (IQR) Median (IQR)
Overall 853 (100) 0.67 (0.63–0.71) 0.13 (0.11–0.16) 0.19 (0.16–0.22)
WC Adequate (p90th) 818 (96) 0.67 (0.63–0.71) 0.13 (0.11–0.16) 0.19 (0.16–0.22)
High (>p90th) 35 (4) 0.67 (0.62–0.70) 0.13 (0.10–0.17) 0.19 (0.17–0.23)
BMI Adequate (≤ p85th) 418 (49) 0.67 (0.63–0.71) 0.13 (0.11–0.16) 0.19 (0.16–0.22)
Overweight (>p85th) 435 (51) 0.67 (0.63–0.71) 0.13 (0.11–0.16) 0.19 (0.16–0.22)
Fasting Glucose Adequate (<100 mg/dL) 829 (97) 0.67 (0.63–0.71) 0.13 (0.11–0.16) 0.19 (0.16–0.22)
High (≥100 mg/dL) 24 (3) 0.68 (0.64–0.71) 0.15 (0.12–0.17) 0.19 (0.15–0.20)
Fasting Insulin Adequate (≤23) 799 (94) 0.67 (0.63–0.71) 0.13 (0.11–0.16)* 0.19 (0.16–0.22)
High (>23,1) 54 (6) 0,66 (0,63–0,70) 0.15 (0.12–0.17) 0.19 (0.16–0.22)
HOMA score Adequate (≤ 3.1) 808 (95) 0.67 (0.63–0.71) 0.13 (0.11–0.16)* 0.19 (0.16–0.22)
High (>3.1) 45 (5) 0.66 (0.63–0.70) 0.15 (0.12–0.17) 0.19 (0.16–0.22)
TG Adequate (< 100 mg/dL) 537 (63) 0.68 (0.63–0.72)** 0.13 (0.11–0.16) 0.19 (0.16–0.22)**
High (≥110 mg/dL) 316 (37) 0.66 (0.63–0.70) 0.13 (0.11–0.16) 0.20 (0.17–0.23)
HDL Adequate (> 40 mg/dL) 689 (81) 0.67 (0.63–0.71) 0.13 (0.11–0.16) 0.19 (0.16–0.22)
Low (≤40 mg/dL) 164 (19) 0.67 (0.63–0.70) 0.13 (0.11–0.17) 0.19 (0.17–0.22)
DBP Adequate (<p90th) 786 (92) 0.67 (0.63–0.71) 0.13 (0.11–0.16) 0.19 (0.16–0.22)
High (≥p90th) 67 (8) 0.67 (0.62–0.70) 0.13 (0.11–0.16) 0.20 (0.18–0.23)
SBP Adequate (p <90th) 811 (95) 0.67 (0.63–0.71)** 0.13 (0.11–0.16)* 0.19 (0.16–0.22)
High (≥p90th) 42 (5) 0.65 (0.61–0.68) 0.15 (0.12–0.18) 0.19 (0.17–0.23)
Data presented in median and interquartile range. BMI body mass index, WC waist circumference, TG triglycerides, HDL high density lipoprotein, DBP diastolic
blood pressure, SBP systolic pressure arterial, IQR interquartile range. Significant differences between groups: U de Mann-Whitney test *P <0.05, **P <0.01
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component in the present study, which showed an associ-
ation with the insulin resistance parameters [36].
No associations of any of the three ancestral compo-
nents were detected with BMI, WC, HDL and glucose
level despite the high heritabilities found for these traits
[37]. Additionally, a relationship to ancestry has been
demonstrated in several studies on populations in the
United States, in which it has been found that adiposity
is higher in EA and Hispanic-American (HA) children
than in AA children [38, 39]. It has been reported that
WC in Mexican-American children is greater than in
EA and AA children [14]. Since 2000, higher levels of
HDL have been reported in both children and adults in
AAs and HAs than in EAs [40]. Based on this evidence,
it was expected that there would be some degree of
association between the genetic components of the
population and these character traits. However, the
negative results presented here could demonstrate that
the association between these traits and the population’s
genetic components is different, not only with respect to
age but also with respect to the ancestral genetic archi-
tecture, which depends on the demographic history of
the population. With respect to studies conducted on as-
sociations with the complete genome, evidence has
shown the existence of genes associated with BMI and
WC in both adults and children, while other associations
are present only in adults or only in children [41]. This
shows the complexity of the inheritance of these traits.
For example, a recent study found an inverse relationship
between 31 loci associated with the risk of obesity, as
Table 3 Multiple logistic regression results for the association of genetic ancestry with components of metabolic syndrome
Phenotype Ancestry OR (CI-95 %)a P-Valuea OR (CI-95 %)b P-Valueb OR (CI-98.3 %)c
BMI European 1.01 (0.99–1.04) 0.314 1.02 (0.99–1.04) 0.207 1.01 (0.99–1.05)
African 0.99 (0.96–1.02) 0.556 0.98 (0.95–1.01) 0.317 0.98 (0.95–1.02)
Amerindian 1.35 (0.95–1.02) 0.426 0.99 (0.95–1.02) 0.511 0.99 (0.95–1.03)
WC European 1.00 (0.94–1.06) 0.963 1.00 (0.94–1.07) 0.880 1.00 (0.93–1.09)
African 1.00 (0.93–1.07) 0.954 1.00 (0.93–1.07) 0.946 1.00 (0.91–1.09)
Amerindian 0.99 (0.91–1.08) 0.870 0.99 (0.90–1.08) 0.789 0.99 (0.89–1.10)
Fasting glucose European 1.00 (0.93–1.08) 0.938 1.03 (0.96–1.11) 0.441 1.03 (0.94–1.13)
African 1.04 (0.97–1.12) 0.217 1.02 (0.95–1.10) 0.532 1.02 (0.94–1.11)
Amerindian 0.92 (0.82–1.02) 0.112 0.90 (0.81–1.00) 0.062 0.90 (0.79–1.03)
Fasting insulin European 0.98 (0.94–1.03) 0.484 0.97 (0.92–1.03) 0.367 0.97 (0.91–1.04)
African 1.03 (0.98–1.08) 0.234 1.05 (0.99–1.11) 0.119 1.05 (0.97–1.13)
Amerindian 0.99 (0.92–1.05) 0.671 0.98 (0.91–1.06) 0.599 0.98 (0.89–1.07)
HOMA score European 0.98 (0.93–1.03) 0.340 0.97 (0.91–1.03) 0.299 0.97 (0.90–1.04)
African 1.03 (0.98–1.09) 0.201 1.05 (0.99–1.12) 0.109 1.05 (0.97–1.14)
Amerindian 0.99 (0.92–1.07) 0.869 0.98 (0.91–1.07) 0.698 0.98 (0.89–1.09)
TG European 0.98 (0.95–1.00) 0.049 0.98 (0.95–1.01) 0.120 0.98 (0.95–1.01)
African 0.99 (0.96–1.02) 0.661 0.98 (0.95–1.02) 0.369 0.98 (0.95–1.02
Amerindian 1.06 (1.02–1.09) 0.002 1.06 (1.02–1.10) 0.002 1.06 (1.01–1.11)
HDL European 1.00 (0.97–1.03) 0.890 1.00 (0.96–1.03) 0.843 1.00 (0.96–1.04)
African 1.00 (0.96–1.03) 0.905 1.00 (0.96–1.04) 0.956 1.00 (0.95–1.05)
Amerindian 1.01 (0.97–1.05) 0.610 1.01 (0.97–1.06) 0.573 1.01 (0.96–1.07)
SBP European 0.93 (0.88–0.97) 0.003 0.93 (0.88–0.99) 0.008 0.93 (0.87–0.99)
African 1.08 (1.03–1.13) 0.002 1.07 (1.02–1.13) 0.008 1.07 (1.01–1.14)
Amerindian 1.01 (0.94–1.09) 0.706 1.01 (0.94–1.09) 0.728 1.01 (0.92–1.11)
DBP European 0.98 (0.94–1.02) 0.399 0.98 (0.94–1.03) 0.433 0.98 (0.93–1.04)
African 0.98 (0.93–1.04) 0.538 0.98 (0.92–1.04) 0.504 0.98 (0.91–1.05)
Amerindian 1.05 (0.99–1.12) 0.078 1.06 (0.99–1.12) 0.078 1.06 (0.98–1.14)
aUnivariate analysis
bAll models have been adjusted for gender, age, pubertal maturation, socioeconomic stratum, physical activity, percent of calories from simple carbohydrate and
consumption of fruits daily. The models for WC, fasting glucose, fasting insulin, HOMA score, TG, HDL, DBP and SBP have also been adjusted for BMI. The significant
p values (P< 0.05) are given in bold. The comparison was statistically significant according to the prespecified Bonferroni-corrected threshold of P <0.0167, but not for
the global correction P <0.0018
c 98.3 % Confidence Intervals (CI) are presented to be consistent with a Bonferroni correction
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defined by BMI, and changes in weight in relation to age
[42].
The results of this study seem to agree with the ideas
of Joshi et al. [42], which suggest directional dominance.
They assessed whether homozygosis in certain regions
of the genome had any directional relationship with
quantitative traits such as height, weight, cognitive mea-
sures and cardio-metabolic parameters, and they found
that only height and cognition clearly presented any dir-
ectional dominance in continental populations. However,
the cardio-metabolic measurements (like those evaluated
in the present study) did not present it, and it was
shown to have a strong variation with age [43].
Conclusion
Here we have shown that although the effect of ancestry
was modest, it was significant, and based on these find-
ings, we suggest that an Amerindian ancestry may act as
a risk factor for high triglycerides, while an African an-
cestral component confers a risk for high systolic blood
pressure. A European ancestry serves as a protective fac-
tor for this condition in the young people of the popula-
tion studied here. In addition, our results show that
ancestry is not associated with WC, BMI, HDL or glu-
cose levels. It is necessary to extend this study to include
more AIMs and a greater sample size in the hopes of
replicating these results and, thus, enabling the use of
predictions based on ancestral components, either as
risk or protection factors, to determine prevention strat-
egies or to identify candidate genes for cardio-metabolic
disorders in children.
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